CLASS II Drug recall · Reported 21 Nov 2018 · FDA Enforcement Report

children's allergy (cetirizine hydrochloride) Oral Solution recalled

Taro Pharmaceuticals U is recalling children's allergy (cetirizine hydrochloride) Oral Solution, 1 mg/mL, Antihistamine, distributed nationwide in the US. The recall was initiated on 19 Oct 2018 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot # 313345, Exp 12/18
NDC56062-106
UPC0041415435735, 041415435735
Quantity recalled8328 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0277-2019
FDA event ID
81483
Recalling firm
Taro Pharmaceuticals U, Hawthorne, NY
Manufacturer
Publix Super Markets Inc
Classification
Class II
Status
Terminated
Recall initiated
19 Oct 2018
FDA classified
20 Nov 2018
Reported
21 Nov 2018
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

19 Oct 2018Recall initiated by company
20 Nov 2018Classified by FDA+32 days
21 Nov 2018Published in enforcement report+1 day

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Impurities/Degradation Specifications: unknown impurity higher than the specified limit was detected during routine stability testing.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

children's allergy (cetirizine hydrochloride) Oral Solution, 1 mg/mL, ANTIHISTAMINE, Dye-Free, Sugar-Free, 4 FL OZ (120 mL) bottle, Distributed by Publix Super Markets, Inc., 3300 Publix Corporate Parkway, Lakeland, FL 33811, NDC 56062-106-08, UPC 0 41415 43573 5.

Where it was distributed

Nationwide in the USA

Nationwide

Stores named: Publix

Questions about this recall

Why was it recalled?

Failed Impurities/Degradation Specifications: unknown impurity higher than the specified limit was detected during routine stability testing.

Which lots are affected?

Lot # 313345, Exp 12/18

Where was it sold?

Nationwide in the USA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

2 other products · FDA event 81483

More recalls from Taro Pharmaceuticals U

All 36

Other Cetirizine recalls

All 18